Supports preclinical study of systemic copper-peptide administration, complementing the more common topical and injectable copper-peptide research models
A.JensenT
Tirzepatide 15 mg produced 5.5 kg more weight loss than semaglutide 1 mg (p 25,000 participants in the SURPASS and SURMOUNT programs [1, 2, 3]: Gastrointestinal effects (most common, dose-dependent): Nausea: 12-18% (5 mg), 15-22% (10 mg), 18-28% (15 mg) vs
Consequently, factors that are challenging to regulate, such as the intensity and composition of natural light, could influence the process
A proof of concept study establishing Necator americanus in crohn's patients and reservoir donors
Among secondary amine nucleophiles, dimethylamine ( b28 ) was an excellent substrate for Cp1D, while bulkier amines were not accepted (Supplementary Fig